2 results
Approved WMORecruiting
To determine the influence of esomeprazole on the AUC of regorafenib in patients with mCRC or GIST.
Approved WMORecruiting
General aim; To dertemine if an alternating regimen of imatinib and regorafenib has sufficient activity and safety to warrant further evaluation as a first line treatment for metastatic GIST.